1800 244 735

An Open Letter to the Australian Huntington’s Community

On 23 March 2021, the news began rolling out across the world that Roche would stop administering the treatments or placebos to patients in the GENERATION HD1 trial. More information will become available in the next weeks and months. The news from the study data analysis this week, however, suggests that in the current GENERATION HD1 trial, there is not enough benefit from the drug to support continued treatment. Roche is clear that the reason for stopping the drug does not relate to new concerns about the safety of the treatment. Importantly, Roche has not said they are stopping its HD program overall. The coming months may reveal Roche’s plans for HD following GENERATION HD1.

Since the news from Roche came out, Australian clinicians, state organisation leaders, and Huntington’s researchers have been meeting on teleconferences to discuss what this means for the Australian Huntington’s disease community. We share your disappointment at the sudden news that the treatment aspect of the trial has been stopped. But we also remain optimistic about the future.

 

What does this news from Roche mean for the HD community?

The Roche trial will leave us all with many valuable learnings to apply in future trials. And many more very promising treatments are being explored in research studies. For example, here in Australia, we have two very important trials underway across five sites in four cities: Brisbane, Sydney, Perth and Melbourne. These trials are sponsored by Wave Life Sciences, a company based in Boston, USA. Wave is getting ready to start a third trial, which will also roll out in Australia. Outside of Australia, at least 10 more HD trials are underway or getting started, all with significant financial investment. We have a lot more treatments to try, and research will continue until treatments are found.

We are very grateful to those people who have volunteered for our HD clinical trials so far, and to the many of you who have participated in research. Australia is a key research hub, recognised internationally for our work in HD. We need the Australian HD community to continue giving their time and energy, so that together we can move closer to treatments that make a real difference for families with HD. Everyone can help. This includes people with HD, their family members, clinicians and support workers of all kinds, and our state organisations.

Across Australia, we are committed to making things better for families with HD, with better treatments, care, and support. Despite the very disappointing news this week, we remain full of energy, and we will continue to work as a united Australian community to do whatever is necessary so that every person who is affected by HD can live their best life.

 

Written collectively by the CEOs of Australian Huntington’s Associations with leading national HD clinicians and researchers

Huntington’s NSW ACT, Huntington’s WA, Huntingtons Queensland, Huntington’s SA & NT, Huntington’s Tasmania, Huntington’s Victoria

 

Clinical trials: your questions answered

Latest News and Stories

We are so close to merging into Huntington’s Australia

Published date: 14 September, 2023

We are now only a matter of weeks away from commencing business as Huntington’s Australia (HA). It has been an enormous effort from so many people to get us to this stage, where we are standing on the precipice of a new, interconnected, national approach to providing supports and services to the Australian HD community.

We are recruiting – Fundraising & Events Coordinator

Published date: 4 August, 2023

Huntington’s Australia is a national leader in the delivery of services to support and empower people impacted by Huntington’s Disease (HD) to live their best life. We provide NDIS services, community education, individual and group capability building activities and advocacy at all levels. As part of the Business Development, Fundraising and Partnerships Team this role ... Read more
HD news image

HD News Winter 2023

Published date: 31 July, 2023

Download your copy of HD News Winter edition by clicking on the link. Some of the highlights in this edition are Introduction to our HD Youth Specialist and program update, HD Awareness Month and the High Tea 4 HD, an update on the progress of Huntington's Australia, dates and registration details for Walk 4 Hope.
donate scene cartoon

We are recruiting – HD Specialist

Published date: 5 July, 2023

Huntington’s NSW ACT is the peak body representing the Huntington’s community in NSW and the ACT. We support people affected by Huntington’s Disease (HD) to live their best possible life, while striving to eliminate the factors that make our organisation necessary. We provide leadership in Huntington’s disease information, education, awareness, support and advocacy. 

Merger date delayed for Huntington’s Australia

Published date: 8 June, 2023

As a valued member of the HD community, we’d like to keep you up to date with Huntington’s Australia (HA) developments. A summary of the article: Our NDIS registration is taking longer than expected and as such the merger date of 1 July has been postponed. The different associations are working together to share resources ... Read more

An update on all things Huntington’s Australia

Published date: 29 March, 2023

As a valued member of the HD community, we’d like to keep you up to date with Huntington’s Australia (HA) developments. The merger implementation is in full swing and just about everyone is getting involved in some way, shape or form. All staff are in the process of having discussions with our CEO, Lenni, and our HR Specialist, Lyn, about transitioning into the new HA organisation. We are still expecting that most of the staff employed by State Associations will transfer to HA. In addition to our CEO, we now also have another two of the senior management team selected, and both are starting this month - Leah Atkinson as the Head of Finance and Corporate Services and Basil Mabuza as the Head of Community Programs and Services.